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Salt and fluid absorption is a shared function of many of the body’s epithelia, but its use is
highly adapted to the varied physiological roles of epithelia-lined organs. These functions
vary from control of hydration of outward-facing epithelial surfaces to conservation and
regulation of total body volume. In the most general context, salt and fluid absorption is
driven byactive Naþ absorption. Cl2 is absorbed passively through various available paths in
response to the electrical driving force that results from active Naþ absorption. Absorption of
salt creates a concentration gradient that causes water to be absorbed passively, provided the
epithelium is water permeable. Key differences notwithstanding, the transport elements used
for salt and fluid absorption are broadly similar in diverse epithelia, but the regulation of these
elements enables salt absorption to be tailored to very different physiological needs. Here we
focus on salt absorption by exocrine glands and airway epithelia. In cystic fibrosis, salt and
fluid absorption by gland duct epithelia is effectively prevented by the loss of cystic fibrosis
transmembrane conductance regulator (CFTR). In airway epithelia, salt and fluid absorption
persists, in the absence of CFTR-mediated Cl2 secretion. The contrast of these tissue-specific
changes in CF tissues is illustrative of how salt and fluid absorption is differentially regulated
to accomplish tissue-specific physiological objectives.
ABSORPTION IN GLANDS AND INTESTINES
Exocrine glands are generally involved in twomajor physiological functions: secretion of
macromolecules such as enzymes and electro-
lyte fluid into the lumen, and postsecretory
modification of primary secretions by a process
involving absorption of fluid and electrolytes as
they pass through the lumen of the ductal sys-
tem (Fig. 1). For the sake of simplicity, we can
take the sweat gland as a representative example
of exocrine structure and function. The sweat
gland is a morphologically and physiological-
ly simple exocrine model system. The sweat
gland has two morphologically distinct regions:
a secretory coil that secretes isotonic fluid into
its lumen and a reabsorptive duct that reabsorbs
most of the secreted Naþ, Cl2, and HCO3
2 from
the lumen as the primary sweat passes on to
the skin surface to evaporate for cooling (Quin-
ton 1987). Secretion of salt into the lumen of
the secretory coil serves the primary function of
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creating a serosa-to-lumen osmotic gradient to
facilitate secretion of water. Because the primary
function of the sweat gland is to wet the skin
surface for evaporative cooling, losing electro-
lytes along with water from the body is high-
ly undesirable because it can lead to severe
dehydration, electrolyte imbalance, and associ-
ated multi-organ disturbances. This physiolog-
ical threat has been effectively solved in primates
as the primary sweat passes through the reab-
sorptive duct, where most of the secreted salt
is returned by active absorption to the extra-
cellular fluid compartment before the sweat
deposits onto the skin surface. Most exocrine
glands and organs use some variant of this basic
principle; that is, first, a primary secretion of an
isotonic fluid, followed by a subsequent modi-
fication by reabsorption to create a tissue-spe-
cific final secretory product so that different
exocrine glands exploit this process to create
an optimal extracellular aqueous medium to
assist in specific physiological functions. For
example, although conservation of salt and/
or maintenance of electrolyte balance are the
primary goals of the absorptive process in the
sweat gland and the kidney tubules (Quinton
1990; Bhalla and Hallows 2008), airway epithe-
lial cells may exploit this absorptive process to
maintain proper volume and composition of
the airway surface liquid (ASL), which is critical
for keeping the airways clear of infections and
blockage (Widdicombe and Widdicombe 1995;
Welsh 1996; Boucher 2001). The physiological
significance of this process is emphasized by
the fact that abnormal electrolyte absorptive
function can lead to severe pathological condi-
tions such as cystic fibrosis (CF), hypertension,
pseudohypoaldosteronism (PHA), and Liddle



























Figure 1. A simplified model depicting significant transport processes in tight and leaky epithelia. Notice that the
tight epithelia predominantly depend on the amiloride-sensitive epithelial Naþ channel and CFTR anion
channel in the apical membranes for transporting Naþ and Cl2 ions into the cell down the electrochemical
gradient. These epithelia are characterized by relatively high electrical resistance (Rt) and transepithelial poten-
tials (Vt). In contrast, the leaky epithelia predominantly depend on carrier-mediated transporters such as
NaK2Cl and Na nutrient (e.g., Na
þ-glucose) cotransporters, Naþ/Hþ, and Cl2/HCO3
2 exchangers across the
apical membranes. Leaky epithelia are also characterized by relatively low values of Rt and Vt. Although most
epithelia generate a lumen-negative Vt of varying magnitude, proximal convoluted tubules can generate a
lumen-positive Vt (about þ3 mV, attributed to paracellular Cl2 diffusion potential) in the absence of nutrient
transport and decreased luminal NaHHCO3
2 concentration (Kokko 1973). Although the Naþ/Kþ pump plays a
major role in the extrusion of Naþ from the cell in the salt absorption process, the mechanism of Cl2 exit is either
mediated by CFTR or by a carrier-mediated transporter such as the KCl cotransporter in the basolateral
membrane.
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Absorptive Mechanisms Are Tissue Specific
Epithelial cells welded together by tight junc-
tions can accomplish vectorial transport of
NaCl and water. Epithelial cells are polarized
by an apical membrane (APM) and a basolateral
membrane (BLM). Each membrane incorpo-
rates specific ion channels and transport pro-
teins such that in an absorptive epithelium,
NaCl can enter the cell at the APM and exits
the cell across the BLM. Epithelial cells of dif-
ferent exocrine organs use diverse physiological
strategies involving coupled ion cotransporters,
counter-ion exchangers, and ion channels to ab-
sorb salt from the lumen to blood. Significant
differences exist in the mechanisms of salt ab-
sorption across the apical membranes of dif-
ferent epithelial cells so as to be in compliance
with their respective physiological roles in a
particular tissue. Because epithelial water per-
meability varies among tissues, fluid and elec-
trolyte absorption can be either hypo-osmotic
(luminal fluid has lower osmolality compared
with plasma) (Bijman and Quinton 1984; Quin-
ton 1984) or isotonic (luminal fluid has the same
osmolality as plasma). So-called leaky epithe-
lia depend on carrier-mediated Naþ-absorp-
tive mechanisms, and they are generally involved
in isotonic fluid absorption. In contrast, epi-
thelia using ENaC-dependent active salt trans-
port (e.g., sweat glands, cortical collecting duct,
and distal colon) generally tend to be involved
in hypo-osmotic absorption (Quinton 1984;
Devuyst and Guggino 2002), as described in
greater detail in the following discussion.
Isotonic Absorption
Most “leaky” absorptive epithelia (so-called be-
cause of their electrically conductive tight junc-
tions) such as proximal tubules, small intes-
tine, and gallbladder are characterized by the
presence of small trans-epithelial electrical po-
tentials and relatively high water permeability.
These epithelial cells generally use combina-
tions of carrier-mediated transport compo-
nents, such as Naþ/Kþ/2Cl2 and Naþ/Cl2 co-
transporters, as well as Naþ/Hþ and Cl2/
HCO3
2 exchangers and Naþ-coupled nutrient
transporters such as Naþ-glucose and Naþ-ami-
no acid cotransporters, in the apical membrane
(Berschneider et al. 1988; Reuss 1985; Reuss et
al. 1991; Kunzelmann and Mall 2002). For ex-
ample, fluid absorption in the intestine and
proximal tubules is always coupled to the move-
ment of solutes from the lumen. There are sig-
nificant regional differences with respect to the
relative role of the aforementioned carrier-me-
diated transport processes even within the gas-
trointestinal tract and kidney tubules. For ex-
ample, Naþ-dependent glucose and amino acid
transporters play a significant role in the process
of absorption in the jejunum and ileal regions.
In contrast, varying degrees of contribution
from Naþ/Hþ (NHE) and Cl2/HCO3
2 ex-
changers to fluid absorption is observed from
the duodenum to the distal colon (Berschneider
et al. 1987; Quinton 1999). Similarly, along the
nephron, Naþ-dependent nutrient transporters
(e.g., Naþ-glucose cotransporters) in the prox-
imal tubule, NHE in the early proximal convo-
luted tubules, NaCl cotransporters in the distal
convoluted tubules, and Naþ/Kþ/2Cl2 cotrans-
porters and NHE in the thick ascending limb
(Quinton 2007) play tissue-specific roles in ab-
sorptive processes. Even though defective func-
tions of these transporters are associated with
several disease conditions invarious leakyepithe-
lia, most of the abnormalities in carrier-medi-
tated transport processes in cystic fibrosis appear
to be secondary to abnormal CFTR (cystic fibro-
sis transmembrane conductance regulator)–me-
diated Cl2 permeability, as discussed below.
Hypertonic Absorption
In contrast to leaky epithelia, the so-called tight
epithelia are generally characterized by the pres-
ence of relatively large lumen negative trans-ep-
ithelial potentials (,210 mV, lumen negative)
and ion channels involved in electrogenic ab-
sorption of NaCl (Boucher et al. 1991; Quinton
1999; Reddy et al. 1999; Kunzelmann and Mall
2002; Reddy and Quinton 2002). These epithe-
lia are mostly, if not exclusively, involved in hy-
pertonic (with reference to plasma) salt absorp-
tion and therefore tend to be relatively water
impermeable. The human sweat duct, cortical
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collecting duct, colon, and salivary glandular
ducts are examples that share these properties.
The absorptive process in tight epithelia is pre-
dominantly mediated by ENaC channels and
CFTR anion channels in the APM (Reuss et al.
1991; Stutts et al. 1995; Reddy et al. 1999; Kun-
zelmann and Mall 2002), which involves the
following steps: Naþ enters the cells via ENaC
channels down a favorable electrochemical gra-
dient, making the cytosolic side of the apical
membrane more positive and thereby creating
a more favorable electrochemical gradient for
negatively charged Cl2 ions to enter the cells
passively via CFTR Cl2 channels. Intracellular
Naþ is pumped out of the cell by the Naþ/Kþ
pump in the BLM, which pumps three Naþ ions
out of the cell in exchange for two Kþ ions.
Hence, the Naþ/Kþ pump exports one net pos-
itive charge out of the cell, thereby contributing
slightly to the negative electrical potential of the
cell. Cl2 entering the cell is driven out across the
BLM through Cl2 channels down a favorable
electrical gradient created by a more negative
basolateral membrane potential (Welsh 1987;
Reddy and Quinton 1991, 1994; Smith et al.
1996; Kunzelmann and Mall 2002). The BLM
of epithelial cells expresses a predominant Kþ
ion selectivity. The basolateral Kþ channels not
only provide a leakage pathway for extrusion of
excess Kþ accumulated during pump activity
but also play a significant role in maintaining
trans-epithelial electrical potential due to sig-
nificantly larger hyperpolarization of BLM rel-
ative to the apical membrane potential, thereby
providing a significant driving force for vecto-
rial salt transport by epithelial cells (Reddy and
Quinton 1987, 1991; Kunzelmann and Mall
2002). Although the salt absorption creates an
osmotic gradient from lumen to serosa (blood
side), water movement across the tight epithelia
down the osmotic gradient is limited by the
epithelial barrier to water.
CFTR in Salt Absorption
CFTR plays a crucial role in diverse physiolog-
ical functions (regarding absorption and secre-
tion of salt) by numerous epithelial organs
(Quinton 1999). CFTR is also unique among
ion channels with respect to (1) complex mo-
lecular structure (Riordan et al. 1989; Welsh
et al. 1992); (2) multiple regulatory controls in-
volving PKC (Berger et al. 1993; Jia et al. 1997),
PKA (Cheng et al. 1991; Berger et al. 1993; Dul-
hanty and Riordan 1994), PKG (Picciotto et al.
1992; French et al. 1995; Vaandrager et al. 1996,
1998), Ca2þ calmodulin-dependent protein ki-
nases (Picciotto et al. 1992), protein tyrosine
kinases (Gadsby and Nairn 1999), and different
protein phosphatases (Berger et al. 1993; Fischer
et al. 1998; Luo et al. 1998; Gadsby and Nairn
1999); and (3) multifunctional behavior involv-
ing several transport functions (Schwiebert et
al. 1999). Structurally, it is distinguished from
most ion channels by the presence of a regu-
latory domain (R-domain) with multiple con-
sensus phosphorylation sites and two nucleo-
tide-binding domains (NBDs) (Riordan et al.
1989; Welsh et al. 1992). Even though these stud-
ies implicated several kinases and phospha-
tases regulating this channel, we do not know
whether all of these regulatory processes are tis-
sue specific or coexist within most epithelial
cells. Even if these control mechanisms do exist
in vivo, the purpose of such complex regulation
remains puzzling. CFTR regulation involves
both hydrolytic and nonhydrolytic ATP bind-
ing to NBDs (Anderson et al. 1991; Quinton
and Reddy 1991; Ko and Pedersen 1995; Reddy
and Quinton 1996; Randak et al. 1997; Shep-
pard and Welsh 1999). Nonhydrolytic ATP
binding may be required for coupling trans-
epithelial electrolyte transport to cellular energy
charge (Quinton and Reddy 1991). However, it
is intriguing that, unlike most ion channels that
allow passive diffusion of ions (as opposed to
energy-dependent active transport), CFTR uses
ATPenergy during the transport process. Recent
studies have indicated that these multiple con-
trols may play a role in determining the anion
selectivity of the CFTR channel to HCO3
2 and
Cl2 (Reddy and Quinton 2003b). Thus, under-
standing the regulatory mechanisms is essential
not only to better understand how different
mutations selectively affect epithelial Cl2 and
HCO3
2 conductances in CF (Reddy and Quin-
ton 2003b), but also to develop effective thera-
peutic strategies to treat diseases like CF.
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ENaC in Salt Absorption
The central role that ENaC plays in salt ab-
sorption in several diseases including pseudo-
hypoaldosteronism (PHA), Liddle syndrome,
and cystic fibrosis (Schild et al. 1995; Rossier
1996; Hummler and Horisberger 1999; Pilewski
and Frizzell 1999; Schreiber et al. 1999; Schwie-
bert et al. 1999; de La Rosa et al. 2000) empha-
sizes the clinical and physiological significance
of this cation channel in epithelial tissues
(Quinton 2007). ENaC is expressed in the
APM of cells in the salivary gland ducts, sweat
gland ducts, cortical collecting tubules of the
kidney, the distal colon, and the airways (Duc
et al. 1994; Fuller et al. 1995; Stutts et al. 1995;
Rossier 1996). ENaC channels in the kidney are
directly involved in the maintenance of extra-
cellular volume and blood pressure and indi-
rectly involved in the homeostasis of Kþ and
Hþ ions. The reabsorption of Naþ in the corti-
cal collecting tubule generates a lumen-negative
potential that facilitates the secretion of Kþ and
Hþ by the distal nephron. Blocking ENaC with
amiloride or inactivation by mutation leads
to Naþ wasting, hyperkalemia, and metabolic
acidosis. Many regulatory mechanisms such as
the renin–angiotensin–aldosterone axis, anti-
diuretic hormone, and catecholamines modu-
late the activity of the ENaC channels (de La
Rosa et al. 2000). ENaC channels are expressed
in the respiratory tract from the nose to the al-
veoli (de La Rosa et al. 2000). In the lung, ENaC
activity is necessary for fluid handling, in par-
ticular at birth when the transition from a liq-
uid-filled lung occurs (de La Rosa et al. 2000).
The composition of the fluid produced by se-
cretory organs such as salivary glands and sweat
glands is also modified by ENaC channels locat-
ed along the ducts that reabsorb luminal Naþ.
CFTR–ENaC Coordination in the
Apical Membrane
Studies on the sweat duct indicated that
ENaC and CFTR activation are closely coupled
but possibly independent of contemporaneous
phosphorylation by PKA, which may suggest
molecular interactions between the two channel
proteins. The carboxy-terminal motif interact-
ing with PDZ1 or PDZ2 of EBP50 (ERM-bind-
ing phosphoprotein 50) or other related pro-
teins may be important for some aspects of
CFTR function (Hall et al. 1998; Short et al.
1998), which might include CFTR–ENaC in-
teractions. However, we do not know how close-
ly the two channels function in vivo. Recent
studies also indicated that activating G-proteins
and A and G-kinases stimulate both CFTR and
ENaC simultaneously in the human sweat duct.
However, we do not know whether such acti-
vation is due to direct action of the agonists
on the individual channels or to indirect effects
through CFTR interacting with ENaC. Second-
ary changes in intracellular ion composition
seem to control ENaC as well as CFTR channel
functions in a complex fashion. Several studies
have shown that increasing intracellular Cl2
concentration inhibits ENaC activity (Cook
et al. 1998; Kunzelmann and Mall 2002; Reddy
and Quinton 2003a). It is important to note
that activation of CFTR was shown to inhibit
ENaC activity in some experimental model
systems indicating that changes in intracellular
Cl2 activity could be one of the mechanisms by
which ENaC is inhibited (Dinudom et al. 1993;
Reddy and Quinton 2002). Other studies have
also indicated that ENaC activity and resultant
increases in intracellular Naþ cause feedback
inhibition of ENaC (Dinudom et al. 1993).
Changing intracellular Naþ could have indirect
effects on ENaC activity through changing in-
tracellular pH mediated by basolateral NHE ac-
tivity (Fig. 2) (Reddy et al. 2008).
Cell Specificity of ENaC–CFTR Interaction
Studies on the human airway epithelium found
increased Naþ absorption in CF airways, and
some studies in heterologous systems (Boucher
1994b; Knowles et al. 1997; Guggino 1999; Pi-
lewski and Frizzell 1999; Schwiebert et al. 1999)
detected a negative influence on ENaC activity.
No evidence of reciprocal coupling between
ENaC exists in other native tissues where it has
been studied, such as the sweat duct. It is pos-
sible that physiological tissue-specific functions
such as absorption versus secretion determine
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the type of CFTR–ENaC interaction or com-
plicate the interpretation of results. However,
in heterologous systems, overexpressed proteins
may very well skew or adversely affect nor-
mal physiological function. For example, in
CFPAC-1 cells, hyperexpressing CFTR actually
depressed outward-rectifying Cl2 currents and
inward-rectifying Kþ currents (Mohammad-
Panah et al. 1998). Native airway tissues and
primary cultures of airway epithelia consist of
multiple cell types, some of which may secrete
while others absorb NaCl (Welsh 1987; Pilewski
and Frizzell 1999). This possibility raises the
question of whether the proportional activi-
ties of ENaC and CFTR seen in the sweat duct
might be present in some cells but overshad-
owed by functions of others, in more compli-
cated tissues. That is, cAMP-mediated secretion
is decreased or absent in CF epithelia (Boucher
1994b; Sato and Sato 1984; Quinton 1999) so
that a relatively greater loss of secretory trans-
port in the presence of simultaneous absorptive
transport could result in an apparent net in-
crease in Naþ absorption relative to normal tis-
sue (Boucher et al. 1988). In fact, some studies
on human airways suggested an increase in salt
concentration in CF airway surface fluid (Joris
et al. 1993; Zabner et al. 1998; Quinton 1999).
These observations seem consistent with recent
reports suggesting that increased salt concentra-
tion in airway surface fluid may compromise
airway defense mechanisms in CF (Smith et al.
1996; Goldman et al. 1997). Furthermore, re-
cent studies involving human airway epithe-
lia (Itani et al. 2011), the CFTR2/2, and
CFTRDF508/DF508 (Chen et al. 2010; Ostedgaard
et al. 2011) have shown reduced Cl2 but not
Naþ conductance in CF airways. Furthermore,
a recent study on the relationship between air-
way epithelial Cl2 secretion and Naþ absorp-
tion balance has led to the conclusion that
hCFTR overexpression increases basal secretion
but does not regulate Naþ transport in wild-
type mice (Grubb et al. 2012). A consensus on
this topic is still much needed.
EFFECT OF CF ON THE ABSORPTIVE
PROCESSES
Sweat Duct
Absorption of NaCl follows the previously de-
scribed classic model of salt absorption by
epithelia involved in hypertonic absorption.
Naþ and Cl2 ions enter the cell via ENaC and

















Figure 2. A simplified model depicting feedback regulation of salt absorption. The model illustrates that as
intracellular Naþ concentration rises as a function of ENaC activity, the chemical driving force for proton
extrusion by the Naþ/Hþ exchanger (NHE) in the basolateral membrane decreases and allows cytosolic acid-
ification that would negatively feedback and inhibit both ENaC and CFTR activity and limit salt influx across the
apical membrane. The feedback inhibition of salt entry would relax as Naþ is extruded by the Naþ/Kþ pump in
the basolateral membrane. Prevention of salt influx in excess of pump capacity would protect the absorptive cell
from disruptive changes in cell volume during trans-epithelial salt absorption.
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pumped out by the Naþ/Kþ pump in the BLM.
Cl2 diffuses out of the cells through basolateral
CFTR Cl2 channels. It was shown that the CFTR
anion channels are absent in both the BLM
and APM of sweat ducts isolated from CF pa-
tients. Lack of functional expression of CFTR
prevents Cl2 exit across the BLM of CF cells
(Reddy and Quinton 1992). In addition, ab-
sence of CFTR in the APM of CF cells prevents
lumen-to-cell Cl2 diffusion and causes sig-
nificant depolarization (makes the membrane
more positive) of the apical membrane potential
(Reddy and Quinton 1989). APM depolariza-
tion abolishes the electrical driving force and
prevents passive diffusion of Naþ. As a conse-
quence, both Naþ and Cl2 ions are retained in
the lumen, causing significant loss of electro-
lytes during sweating, particularly in patients
afflicted by overheating (Quinton 1999). Thus,
elevated sweat NaCl concentration is the basis
of the classic pilocarpine-induced sweat test
as a diagnostic feature of CF disease (Quinton
1999).
Salivary Glands
The physiology of salivary glands seems to fol-
low the classic pattern of exocrine function in
which the acinar cells of the salivary glands
secrete an isotonic fluid, and the ductal system
reabsorbs the salt from the primary secretion.
The functional properties of salivary gland ducts
appear to mimic closely those of the duct cells
that are involved in hypertonic absorption of
salt from the lumen using ENaC and CFTR
channels. Salt absorption by the salivary ducts
were significantly inhibited by amiloride and
CFTRinh-172 in mouse salivary gland ducts
(Catalan et al. 2010). Unlike in the airways,
where CFTR seems to inhibit ENaC activity,
there is a coordinated activation of CFTR and
ENaC in the salivary duct cells so that inhi-
bition of CFTR in the CF mice resulted in the
increase in both Naþ and Cl2 concentrations
(Reddy et al. 1999; Catalan et al. 2010). There
are inconsistent and conflicting reports on the
effect of CF on salivary gland functions. Ab-
normal Cl2 absorption and HCO3
2 secretions
by the submandibular gland ducts were ob-
served from CF patients (Blomfield et al. 1973;
Davies et al. 1989, 1991; McPherson et al. 1992).
Several studies have indicated functional and
pathological abnormalities in salivary gland
functions. It is well known that CFTR and
ENaC channels play a predominant role in hy-
pertonic salt absorption in human salivary
gland ducts. Early studies indicate elevated
NaCl concentration in the parotid gland se-
cretion from CF patients (Prader and Gautier
1955; di Sant’Agnese 1956; Johnson 1956; Bar-
bero and Sibinga 1962). Increased levels of NaCl
(and defectiveb-adrenergic secretions) (Bergler
et al. 1994a,b; Catalan et al. 2010) were also ob-
served in the submandibular secretions from
mice with the DF508 CFTR mutation (Catalan
et al. 2010).
Small Intestine
There are conflicting reports on the effect of CF
on absorptive process in the intestine. Naþ-de-
pendent nutrient transport is the predominant
mechanism of absorption in the small intes-
tine. Early reports indicated enhanced Naþ-de-
pendent glucose cotransport (Frase et al. 1985).
These observations were supported by the sub-
sequent studies showing increased nutrient-
dependent short circuit currents (Baxter et
al. 1988, 1989, 1990a,b; Hardcastle et al. 1990;
Teune et al. 1996). It is well known that secre-
tion of electrolyte fluid is severely compro-
mised throughout the intestine including the
jejunum and ileum (Berschneider et al. 1987,
1988; Taylor et al. 1987, 1988). Because the nu-
trient absorption is driven by the driving force
for Naþ, absence of a Cl2 shunt due to lack of
CFTR anion channels in the plasma membranes
of CF intestinal epithelium seems to increase
the driving force for Naþ, causing a significant
surge in glucose and other nutrient absorption.
To have an increased driving force for Naþ glu-
cose cotransport, it seems necessary that both
CFTR and Naþ-dependent cotransporters must
be present in the plasma membranes of the
same cell. In fact, a Cl2 conductance resembling
CFTR is colocalized with Naþ/glucose cotrans-
port in rat and human small intestine, support-
ing the possibility that abnormalities in glucose
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absorption in cystic fibrosis may be a secondary
effect of defects in Cl2 channel function (Baxter
et al. 1990a,b; Hardcastle et al. 1990). Russo
et al. (2003) have reported that fluid absorption
processes are, in fact, reduced in CF jejunum
because of a marked depression of passive chlo-
ride absorption, but that Naþ-glucose cotrans-
port in the CF jejunum is normal. In contrast
to human intestine, intestinal glucose absorp-
tion seems reduced in transgenic mouse models
of CF with the DF508 mutation. Therefore, it
was suggested that the transgenic mouse mod-
els of CF might not accurately reflect all aspects
of intestinal dysfunction in the human disease
(Hardcastle et al. 2004). It was further reported
that the Cftr-null mice lacking one or both cop-
ies of the NHE3 (Naþ/Hþ exchanger) gene
exhibited increased fluidity of their intestinal
contents, which prevented the formation of
obstructions and increased survival (Bradford
et al. 2009), indicating that salt absorption in
the face of reduced secretions caused by CFTR
mutations plays a significant role in the devel-
opment of intestinal pathology in CF mice.
However, increased Naþ-dependent nutrient
and fluid absorption in the face of reduced
CFTR-dependent Cl2 secretion in CF intesti-
nal epithelium appears to be a primary cause
of dehydrated luminal content leading to the
pathogenesis of meconium ileus in CF patients
(Berschneider et al. 1988).
Colon
Electrolyte and fluid absorption is the predom-
inant function of the colonic epithelium. The
human colon absorbs large quantities of fluid
and electrolytes per day (1.5 L/d) (Debongnie
and Phillips 1978). Absorptive processes in
the colon are complex and exhibit significant
regional differences. In the ascending colon,
electroneutral transport involving Naþ/Hþ
and Cl2/HCO3
2 exchangers seems to be the pre-
dominant mechanism of absorption. In con-
trast, electrogenic absorption involving ENaC
and CFTR channels appears to play a significant
role in electrolyte fluid absorption in the de-
scending colon (Clauss et al. 1985; Kunzelmann
et al. 2001; Kunzelmann and Mall 2002). Defects
in the absorptive processes were observed in
both electroneutral as well as electrogenic com-
ponents of colonic absorptive processes (Kun-
zelmann and Mall 2001, 2002). Early studies on
CF mouse colons show increased electrogenic
sodium absorption compared with wild-type
tissues. Elevated plasma aldosterone in CF
mice was suspected to be responsible for part
or all of the increased sodium absorption in
CF mouse colons (Cuthbert et al. 1994, 1999).
It was also reported that in both CFTR knock-
out mice and in CF patients, the absence
of CFTR-mediated inhibition of ENaC seems
responsible for increased amiloride-sensitive
short-circuit currents and Naþ absorption in
the colonic epithelium compared with non-CF
controls (Grubb and Boucher 1997; Briel et al.
1998; Mall et al. 1999; Kunzelmann and Mall
2001; Kunzelmann et al. 2001).
Isotonic Salt Absorption by Airway Epithelia
The essential physiological purpose of human
airways is to conduct inspired air to and from
the alveolar surfaces where gas exchange occurs.
Structurally, the lower airways dichotomously
branch from the trachea (2 cm diameter) to
thousands of terminal airways (0.5–1 mm di-
ameter) (Kilburn 1974). The large aggregate
surface of these conducting airways is lined by
a continuous epithelium that is protected from
desiccation by a thin (10 mm) liquid layer
called airway surface liquid (ASL). Additional-
ly, ASL supports the innate immune defense
mechanism of mucociliary clearance of parti-
cles deposited from inhaled air, including infec-
tious agents (Knowles and Boucher 2002). The
airway mucosal surface is kept hydrated and
mucociliary clearance is maintained by regula-
tion of ASL volume and composition through
the fluid transport activities and passive barrier
properties of airway epithelia (Boucher 1994a).
Airway epithelia are equipped both to absorb
Naþ and secrete Cl2, indicative of the impor-
tance of regulating airway surface hydration.
Electroneutrality requires that Naþ cannot be
absorbed without a co-ion, predominantly
Cl2, and neither can Cl2 be secreted without
an co-ion, predominantly Naþ. Thus, ASL
M.M. Reddy and M.J. Stutts



















homeostasis is achieved by balanced isotonic
salt absorption and secretion.
Path for Na1 Absorption
Airway epithelia are composed of ciliated and
nonciliated cells (Kreda et al. 2005). Ciliated
cells not only elaborate the cilia that move ASL
cephalad, but are also the cells that accomplish
salt transport. Nonciliated cells secrete macro-
molecules, used in innate defense, including
mucins, whose physicochemical properties are
dependent on hydration (Kesimer et al. 2010).
The path for Naþ absorption through ciliated
cells consists of entry at the apical membrane
and extrusion from the basolateral membrane.
Entry of Naþ from ASL is rate limiting for Naþ
absorption and is primarily mediated by the
epithelial Naþ channel (ENaC). Other means
of Naþ entry have been considered, such as
Naþ/proton exchange or Naþ/glucose cotrans-
port, but have not been found to play a major
role in airway epithelia. Naþ extrusion across
the basolateral membrane is accomplished by
Naþ–Kþ-ATPase (Knowles et al. 1984). This
transport element is obviously essential for
Naþ absorption by all epithelia, but it does not
appear to be the point of regulation in airway
epithelia. Thus, Naþ absorption in airways is
regulated principally at the ENaC-mediated en-
try step, as discussed below.
Path for Cl2 Absorption
Isotonic absorption of fluid and salt in response
to electrochemical driving forces generated
by active Naþ transport requires a Cl2 conduc-
tance. Cl2 is predicted to diffuse across the
epithelium through available cellular and para-
cellular routes. The paracellular path of air-
way epithelia has the properties of free solution
(Cotton et al. 1983). The further observation
that the ratio of Cl2 to mannitol trans-epithe-
lial permeability coefficients exceeds the ratio
of their free solution diffusivities suggests that
a trans-cellular, in addition to a paracellular,
route is available for passive Cl2 diffusion
(Stutts et al. 1988). Trans-cellular cellular Cl2
absorption requires Cl2 entry across the apical
membrane. Although most work on the ele-
ments of Cl2 movement across airway epithelia
has focused on Cl2 secretion, ion channels in the
apical cell membrane including CFTR and other
Cl2 channels, such as ano1, provide an apical
Cl2 conductance for Cl2 to enter or leave the
cell, depending on the existing Cl2 electrochem-
ical potential (Willumsen et al. 1989; Tarran
et al. 2002; Ferrera et al. 2010). Moreover, airway
epithelia express SLC family members that ex-
change intracellular HCO3
2 for extracellular
Cl2 (Mount and Romero 2004). Cl2 movement
from cell to interstitium is thought to require
a Cl2 basolateral cell membrane conductance,
for which electrophysiological data exist, but for
which no molecular identity is known (Reddy
and Quinton 1992; Uyekubo et al. 1998).
Relationship between Na1 Absorption
and Cl2 Secretion in Airways
Studies in thin film preparations confirm that
both Naþ absorption and Cl2 secretion are used
to control the depth of liquid on the airway
surface (Tarran et al. 2002, 2006). This duality
of salt transport mechanisms is extensively doc-
umented in studies of freshly excised airway ep-
ithelia of many species (Olver et al. 1975), in-
cluding human (Boucher et al. 1991). Ion flux
data from decades of studies show an absorp-
tion flux of Naþ that exceeds passive backflux
under both short circuit and open circuit con-
ditions (Boucher 1994a,b; Mall 2009), consis-
tent with a classic passive Naþ entry from the
luminal solution via ENaC with active extrusion
of Naþ by the basolateral Naþ/Kþ ATPase (Us-
sing et al. 1974). This net flux is eliminated by
amiloride-like ENaC blockers and by ouabain,
an inhibitor of the Naþ/Kþ pump (Olver et al.
1975). The same studies have characterized Cl2
secretion by airway epithelia as a secondary
active ion transport process (Olver et al. 1975;
Boucher et al. 1980). That is, Cl2 is not actively
transported per se but is accumulated in air-
way cells above its predicted electrochemical
potential by a basolateral cotransporter that
use Naþ, Kþ, and Cl2 gradients supported by
the Naþ/Kþ pump (Frizzell et al. 1979). Passive
Cl2 conductance in the apical membrane allows
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Cl2 accumulated above its electrochemical po-
tential to exit into the luminal solution, creating
net Cl2 secretory transport (cf. Frizzell and
Hanrahan 2013). Consistent with the passive
nature of this process, Cl2 secretion by airway
epithelia responds to maneuvers that hyper-
polarize the apical membrane potential. Such
maneuvers prominently include Naþ channel
blockers and clamping trans-epithelial poten-
tial difference to zero (so-called short circuit
conditions). Even so, under open circuit con-
ditions and in the absence of amiloride, net
absorption of both Naþ and Cl2 has been
documented in native human (Knowles et al.
1984) and canine bronchial epithelium (Bou-
cher et al. 1981).
Water Permeability of Airway Epithelia
A striking characteristic of airway epithelia that
sets it apart from sweat ductal epithelia is its
significant water permeability (Matsui et al.
2000; Verkman et al. 2000). Decreased water
permeability is detected in alveoli and airways
mice with knocked-down expression of aqua-
porins, but ASL hydration was unaffected
(Verkman 2007). This result was attributed to
the relatively small flux of water across airway
epithelia, compared with the overall non-aqua-
porin routes available for water diffusion across
airway epithelia (AS 2007). Accordingly, water
permeability is not expected to be limiting for
fluid absorption by airway epithelia.
Regulation of ENaC
Net salt and fluid absorption, that is, the net of
active Naþ absorption (with passive Cl2) and
Cl2 secretion (with passive Naþ), is determined
by the driving forces established in response
to Naþ conductance of the apical membrane.
When Cl2 conductance is predominant owing
to the activation of CFTR and Naþ conductance
is blocked or very small, the apical membrane
should hyperpolarize sufficiently to support
Cl2 secretion. As Naþ conductance increases,
the apical cell membrane must depolarize and
diminish the driving force on Cl2 to passing
from cell to lumen (secretion). At some point
as Naþ conductance increases, the net driving
force on Cl2 reverses and Cl2 is no longer se-
creted but moves in the absorptive direction to
support net Naþ and Cl2 (and fluid) absorp-
tion. Because apical Naþ conductance is prin-
cipally due to ENaC, with a small component of
nonselective cation conductance of uncertain
molecular origin, regulation of ENaC in airway
epithelia is effectively the regulator of fluid ab-
sorption.
ENaC Structure and Stoichiometry
ENaC is a heteromeric channel composed ofa-,
b-, and g-subunits (Canessa et al. 1994b). Each
subunit has two membrane-spanning regions
with short amino and carboxyl cytoplasmic
tails. The membrane-spanning regions of each
subunit are joined by a large extracellular do-
main (Canessa et al. 1994b). ENaC belongs to a
family of channels with similar topology that
include acid-sensing channels (ASICs) (Kellen-
berger and Schild 2002). ASIC1 has been crys-
tallized, revealing a homotrimeric structure
(Jasti et al. 2007). This was taken as a strong
indication that ENaC has a trimeric structure
of a-, b-, and g-subunits (Stockand et al.
2008), but at this time, ENaC stoichiometry re-
mains a controversial question (Anantharam
and Palmer 2007).
ENaC trafficking to and from the apical
membrane involves regulated processes that de-
termine the density of ENaC in the apical mem-
brane (Palmer et al. 2012). Liddle’s disease of
inherited amiloride-sensitive hypertension is
caused by mutations in the carboxy-terminal
cytosolic tails of b- and g-ENaC, which contain
highly conserved PY protein interaction mo-
tifs that mediate the association of ENaC with
the E3 ubiquitin ligase, Nedd4-L (Schild et al.
1996; Staub et al. 2000). Nedd4-L catalyzes
ubiquitinylation of ENaC cytosolic amino-ter-
minal lysines, and this posttranslational mod-
ification causes ENaC internalization (Rotin
2000). Numerous signaling pathways, includ-
ing SGK1, PKA, and MAP kinases, adjust the
strength of the ENaC–Nedd4-L association
through the phosphorylation status of specific
residues, giving rise to wide tissue variability
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in the impact of this regulatory axis (Debon-
nevilles et al. 2001). For example, the hyper-
tension of patients with Liddle’s disease is at-
tributed to excess ENaC at the apical membrane
of renal tubules (Palmer et al. 2012). However,
Liddle’s disease patients show no evidence of
increased Naþ absorption in respiratory epi-
thelia (Knowles and Boucher 2002), suggest-
ing that other mechanisms exist for controlling
Naþ conductance in certain tissues. Nonethe-
less, Nedd4-L must provide the underlying
mechanism of retrieval of ENaC from the sur-
face of airway epithelial cells, because mice with
lung-specific Nedd4-L knockdown developed
Naþ hyperabsorption and fatal lung disease (Ki-
mura et al. 2011).
ENaC activity at the apical membrane is also
subject to regulation by signaling that influ-
ences channel open probability (PO). ENaC is
stimulated by proteases that cleave sites within
the extracellular domains of ENaC (Vuagni-
aux et al. 2000; Hughey et al. 2004). This action
acutely increases PO (Caldwell et al. 2004, 2005).
Although still not completely understood, it
now appears that cleavage at defined sites with-
in the extracellular domains of a- and g-ENaC
results in conformational changes that allow
greater stability of the open state of the chan-
nel (Kashlan et al. 2011). It is also evident that
numerous proteases can cleave and activate
ENaC and that their catalytic activity is opposed
by cognate protease inhibitors (Myerburg et
al. 2008; Passero et al. 2008; Svenningsen et al.
2009). Thus, the stimulation of ENaC through
extracellular proteolysis is likely to be intri-
cately balanced and will depend on the coinci-
dence of proteases and inhibitor expression
with ENaC.
ENaC PO is strongly stimulated by binding
to membrane phosphoinositides through ba-
sic residues in the cytosolic amino termini, es-
pecially b- and g-ENaC (Ma et al. 2002; Yue
et al. 2002). Numerous reports have established
that exogenous PIP2 or PIP3 is a strong stim-
ulate of ENaC, such that signaling mechanisms
that affect the abundance of these phosphoino-
sitides clearly influence ENaC-mediated Naþ
absorption (Kunzelmann et al. 2004; Wang
et al. 2008).
Regulation of ASL Depth by Embedded
Signals in Normal and CF Airways
ENaC-mediated Naþ conductance strongly af-
fects the electrical potential difference across the
apical membrane of airway epithelia (Willum-
sen et al. 1989; Willumsen and Boucher 1991),
which determines the balance between isotonic
fluid absorption and fluid secretion. Tarran and
others, using “thin film” or “air–liquid inter-
face” culture techniques, showed that airway
cells cultured under conditions that mimic the
10-mm depth of ASL maintained in vivo rely
on soluble signals in the small volume on the
culture surface to regulate ENaC (Tarran et al.
2001, 2005; Song et al. 2009). In fact, this work
identified both protease inhibitors as well as
nucleotides as the major inhibitory regulators
of ENaC. As ASL depth is reduced, the concen-
tration of these ENaC inhibitory signals in-
creases, slowing NaCl absorption (Myerburg
et al. 2006, 2010; Tarran et al. 2006). Moreover,
ATP can stimulate Ca2þ-dependent Cl2 con-
ductance in the apical membrane, and adeno-
sine arising from the catabolism of ATP can
stimulate CFTR activity. With ENaC inhibited,
driving forces for Cl2 secretion can be achieved.
In this manner, airway epithelia can temper, or
even reverse, the absorption of NaCl and H2O to
maintain optimal airway surface hydration.
These approaches revealed a striking difference
between ASL homeostasis in differentiated cul-
tures derived from normal and CF airways. CF
cultures were unable to switch from absorption
to secretion, leading to collapse of ASL depth
(Tarran et al. 2006). This result was not unpre-
dicted, given the absence of CFTR to mediate
Cl2 secretion in the CF cultures. However, it was
also clear that ENaC remained hyperactive, even
as ASL height decreased. A potential basis for
ENaC hyperactivity in CF was detected in two
laboratories as a much greater extent of ENaC
cleavage in differentiated CF cultures compared
with normal cultures (Myerburg et al. 2006;
Gentzsch et al. 2010). Coexpression of CFTR
in Xenopus oocytes with ENaC strongly de-
pressed ENaC proteolysis and amiloride-sensi-
tive currents. Taken together, these results con-
firm the role of CFTR-mediated Cl2 secretion in
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homeostatic control of ASL volume and fur-
ther implicate loss of CFTR-mediated inhi-
bition of ENaC proteolysis/stimulation as a
potential cause of the dysregulated Naþ absorp-
tion that has been reported in CF airways.
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